We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information for patients, healthcare professionals and developers of new medicines
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
Information on the clinical management of acute flaccid paralysis (AFP) and acute flaccid myelitis (AFM), for use by healthcare professionals.
New 10-year plan to expand and improve the drug and alcohol workforce published.
Information on carrying medicine containing controlled drugs for individual travellers entering or leaving the UK.
Volume 37 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Practical advice for clinicians caring for immunocompromised persons who wish to travel or who have travelled to Zika-affected countries or areas.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
The Defence and Security Accelerator on behalf of the Office for Veterans' Affairs (Cabinet Office) is seeking proposals that will improve Veteran health.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).